Monthly Archives: November 2012

Missing the Obvious

The LA Times recently ran a front-page special report on the toll taken by overdoses of narcotic prescription pain meds–15,500 deaths per year in the US, according to CDC figures. The report focused on the issue of physicians who overprescribe, … Continue reading

Posted in Uncategorized | Tagged , , , , | Leave a comment

The Last Shoe Drops for Solanezumab

Just a tad too late for inclusion in the November issue of NeuroPerspective, the biomarker data for solanezumab were presented, at the CTAD meeting in Monte Carlo. As we had noted in a previous post (‘Chinese Data Torture’),  the data … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment